Envista Holdings Co. (NYSE:NVST) Receives $19.14 Average Price Target from Analysts

Envista Holdings Co. (NYSE:NVST) has been assigned a consensus recommendation of “Hold” from the fourteen ratings firms that are currently covering the stock, MarketBeat.com reports. Three research analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have issued a buy rating on the company. The average 12-month target price among analysts that have issued a report on the stock in the last year is $19.59.

A number of equities analysts have recently weighed in on the stock. Bank of America reduced their price target on shares of Envista from $22.00 to $19.00 and set a “buy” rating on the stock in a research report on Thursday, August 8th. Needham & Company LLC restated a “hold” rating on shares of Envista in a report on Thursday, August 8th. JPMorgan Chase & Co. cut Envista from an “overweight” rating to a “neutral” rating and cut their price objective for the company from $23.00 to $16.00 in a report on Thursday, August 8th. Stifel Nicolaus decreased their price objective on Envista from $20.00 to $18.00 and set a “buy” rating for the company in a research report on Tuesday, July 30th. Finally, Piper Sandler dropped their target price on shares of Envista from $18.00 to $16.00 and set a “neutral” rating on the stock in a report on Tuesday, July 30th.

Insiders Place Their Bets

In related news, CFO Eric D. Hammes purchased 24,532 shares of Envista stock in a transaction that occurred on Monday, August 12th. The stock was purchased at an average cost of $16.33 per share, with a total value of $400,607.56. Following the completion of the transaction, the chief financial officer now owns 24,532 shares of the company’s stock, valued at approximately $400,607.56. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Insiders own 1.30% of the company’s stock.

Institutional Trading of Envista

A number of hedge funds have recently made changes to their positions in the business. Versant Capital Management Inc lifted its position in Envista by 1,420.3% during the second quarter. Versant Capital Management Inc now owns 3,147 shares of the company’s stock worth $52,000 after acquiring an additional 2,940 shares during the last quarter. Quadrant Capital Group LLC boosted its stake in Envista by 538.0% in the 4th quarter. Quadrant Capital Group LLC now owns 3,209 shares of the company’s stock valued at $77,000 after purchasing an additional 2,706 shares during the period. Innealta Capital LLC acquired a new position in Envista in the 2nd quarter valued at $78,000. Summit Securities Group LLC bought a new position in Envista during the 2nd quarter worth $85,000. Finally, Signaturefd LLC lifted its holdings in shares of Envista by 85.9% during the second quarter. Signaturefd LLC now owns 5,345 shares of the company’s stock worth $89,000 after buying an additional 2,470 shares in the last quarter.

Envista Stock Performance

NVST stock opened at $19.04 on Friday. Envista has a twelve month low of $15.15 and a twelve month high of $28.67. The company has a quick ratio of 1.90, a current ratio of 2.22 and a debt-to-equity ratio of 0.47. The company has a market cap of $3.27 billion, a P/E ratio of -26.44 and a beta of 1.31. The business’s fifty day moving average is $17.49 and its 200-day moving average is $18.46.

Envista (NYSE:NVST) last posted its earnings results on Wednesday, August 7th. The company reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.27 by ($0.16). Envista had a positive return on equity of 4.86% and a negative net margin of 52.25%. The company had revenue of $633.10 million for the quarter, compared to analyst estimates of $646.88 million. During the same quarter in the previous year, the firm posted $0.43 earnings per share. Envista’s quarterly revenue was down 4.4% compared to the same quarter last year. Equities research analysts forecast that Envista will post 0.69 EPS for the current year.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.